Therefore, we speculated that lipocalin is complex and bidirectional in the inflammatory response to COPD, and it can activate pro-inflammatory mechanisms by upregulating the levels of pro-inflammatory factors, while its anti-inflammatory mechanisms may be largely dependent on regulatory mechanisms with SP-D. This evidence concerns the gene SFTPD and chronic obstructive pulmonary disease.